Alignment Healthcare, Inc. Announces Results of 2026 Annual Meeting of Stockholders
Alignment Healthcare, Inc. (NASDAQ: ALHC) has released the results of its regular annual meeting of stockholders, held virtually on June 4, 2026. The meeting addressed several critical proposals, including the election of directors, ratification of the Company’s independent auditor, and an advisory vote on executive compensation. A total of 194,112,992 shares of common stock were represented at the meeting.
Key Points and Shareholder-Relevant Details
-
Election of Class II Directors:
- Three Class II directors were elected to serve three-year terms, lasting until the 2029 annual meeting or until their successors are elected and qualified.
- The directors and the results were:
- Jody Bilney: 135,714,231 votes FOR, 42,598,200 votes WITHHELD, 15,800,560 Broker Non-Votes.
- David Hodgson: 108,386,550 votes FOR, 69,925,881 votes WITHHELD, 15,800,560 Broker Non-Votes.
- Jacqueline Kosecoff: 135,613,817 votes FOR, 42,698,614 votes WITHHELD, 15,800,560 Broker Non-Votes.
- The substantial ‘withhold’ votes for Mr. Hodgson (nearly 40% of represented votes) may warrant investor attention regarding shareholder sentiment on his continued service on the Board.
-
Ratification of Independent Auditor:
- The appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026, was ratified by an overwhelming majority:
-
- Votes FOR: 194,030,577
- Votes AGAINST: 13,893
- Abstentions: 68,522
- No indication of shareholder discontent with the Company’s choice of auditor.
-
Say-on-Pay Advisory Vote:
- The executive compensation of named executive officers was approved on an advisory basis:
-
- Votes FOR: 169,068,300
- Votes AGAINST: 8,701,941
- Abstentions: 542,191
- Broker Non-Votes: 15,800,560
- The strong approval of the Company’s pay practices signals general shareholder satisfaction with executive management.
Additional Information Relevant to Investors
-
Company Information:
Alignment Healthcare, Inc. is incorporated in Delaware and headquartered at 1100 W. Town and Country Road, Suite 1600, Orange, CA 92868. -
Trading Information:
The Company’s common stock trades on the NASDAQ Stock Market LLC under the symbol ALHC. -
Emerging Growth Company Status:
Alignment Healthcare, Inc. is not classified as an emerging growth company, as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.
Potential Price-Sensitive Items
- Board Elections: The significant number of ‘withhold’ votes for David Hodgson might signal investor concerns about Board composition, governance, or past performance. While all directors were elected, such voting outcomes can lead to increased scrutiny or calls for change by activist investors or governance watchdogs.
- Say-on-Pay Approval: Strong support for executive compensation is a positive signal for management stability and alignment with shareholder interests, which may be viewed favorably by institutional investors.
- No Indication of Major Governance or Audit Concerns: The overwhelming support for the independent auditor and no indication of material shareholder dissent reduce the likelihood of negative surprises in governance or financial oversight matters.
Conclusion
Overall, the 2026 annual meeting results for Alignment Healthcare, Inc. reflect strong support for management and the Board, with the notable exception of a large ‘withhold’ vote for one director. No proposals failed, and there were no shareholder proposals or other matters that could significantly impact share value in the immediate term. However, investors may wish to monitor future disclosures or governance developments in response to the elevated ‘withhold’ tally for Mr. Hodgson.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should consult their own advisors and review original company filings before making any investment decisions. The information presented is based on Alignment Healthcare, Inc.’s Form 8-K filed for the annual meeting held on June 4, 2026, and may not include all developments relevant to the Company.
